Harmonized and Integrated with Highly Intuitive Analytics for Use in Designing Protocols and Conducting Observational Research
Barcelona, Spain – ISPOR Europe – November 12, 2018 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence, today announced it has added ambulatory care, medical claims, and pharmacy claims from 190 million patients to its research platform.With TriNetX, researchers are now able to quickly query and analyze claims data without the cost and complexity of licensing, mapping, and hosting the data. The TriNetX Diamond Network™, covering 1.8 million providers and 99 percent of U.S. health plans, is available through TriNetX’s user-friendly interface and has been seamlessly integrated with state-of-the-art analytics to support clinical trial optimization and observational research.
“Claims data is a critical component of real-world evidence within the healthcare industry,” said Jennifer Stacey, Vice President, Clinical Sciences at TriNetX. “The addition of the Diamond Network truly enhances our clients’ ability to understand market dynamics and make strategic medical decisions. This robust network is extremely powerful for hypothesis generation, clinical outcomes research, and conducting studies derived from real-world data.”
TriNetX enables teams to quickly create real-world evidence by providing web-based, on-demand access to harmonized clinical and claims data with a suite of highly intuitive analytics. The longitudinal clinical and claims data representing over 300 million patients that’s available through TriNetX is mapped to controlled terminology, and consists of:
• Clinical facts from hundreds of healthcare organizations, who comprise TriNetX’s global health research network
• Deep specialty data for cardiovascular and oncology
• Linked medical claims, pharmacy claims and EMR
• Multiple clinical data types including, demographics, diagnoses, procedures, vitals, medications, labs, patient location, tumor registry, genomics, facts extracted from physician notes and other unstructured data
“The availability of claims data represents the next step toward making TriNetX the primary, go-to resource for on-demand research-grade data and analytics,” said Alex Eastman, Vice President, Product Management at TriNetX. “Where up to 80 percent of most data analysis time is spent wrangling and mapping data, TriNetX has curated and harmonized the data so that it is analysis-ready at login.”
TriNetX is the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real time access to longitudinal clinical data with state-of-the-are analytics to answer complex research questions at the speed of thought. For more information, visit TriNetX at http://www.trinetx.com or follow @TriNetX on Twitter.
+1 (857) 285-6052